Literature DB >> 28843098

Prevalence and characteristics of inhalational and dermal palytoxin exposures reported to the National Poison Data System in the U.S.

Lauren T Murphy1, Nathan P Charlton2.   

Abstract

INTRODUCTION: Palytoxin, produced by unicellular microalgae, is one of the most potent toxins known. Human exposure results most prominently through oral, dermal, and inhalational contact. There is no current data on the prevalence of cases in the United States.
METHODS: This study reviewed human inhalational and dermal exposures to palytoxin via records from the National Poison Data System from 2000 to 2014.
RESULTS: There were 171 cases reported, the majority occurred at a residence and experienced minor respiratory or dermal symptoms and recovered without any major sequelae or fatalities. Ten patients required admission to an intensive care unit.
CONCLUSION: The incidence of palytoxin exposure is low but significant symptoms can occur.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Algae; Coral; Exposure; Palytoxin; Poisoning; Toxicity

Mesh:

Substances:

Year:  2017        PMID: 28843098     DOI: 10.1016/j.etap.2017.08.010

Source DB:  PubMed          Journal:  Environ Toxicol Pharmacol        ISSN: 1382-6689            Impact factor:   4.860


  3 in total

Review 1.  Human Poisoning from Marine Toxins: Unknowns for Optimal Consumer Protection.

Authors:  Natalia Vilariño; M Carmen Louzao; Paula Abal; Eva Cagide; Cristina Carrera; Mercedes R Vieytes; Luis M Botana
Journal:  Toxins (Basel)       Date:  2018-08-09       Impact factor: 4.546

2.  A Sensitive LC-MS/MS Method for Palytoxin Using Lithium Cationization.

Authors:  Mirjam D Klijnstra; Arjen Gerssen
Journal:  Toxins (Basel)       Date:  2018-12-14       Impact factor: 4.546

3.  In Vivo Evaluation of the Chronic Oral Toxicity of the Marine Toxin Palytoxin.

Authors:  Andrea Boente-Juncal; Sandra Raposo-García; Carmen Vale; M Carmen Louzao; Paz Otero; Luis M Botana
Journal:  Toxins (Basel)       Date:  2020-07-30       Impact factor: 4.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.